Clinical Research Directory

Inclusion Criteria: 1. Adult patients ≥ 18 years of age with chronic kidney disease and hyperkalemia 2. Chronic kidney disease is defined as eGFR 15-44ml/min/1.73m2 3. Documented hyperkalemia which is defined as serum potassium ≥ 5.0 mmol/L during the last 90 days 4. Diet evaluation for hyperkalemia (serum potassium ≥ 5.0) during the last 90 days 5. Patients receiving RASS inhibitors, beta-blockers, or diuretics to be on stable doses for 2 weeks 6. Patients already receiving patiromer are eligible Exclusion Criteria: 1. Patients with a known allergy to patiromer 2. Patients currently taking other potassium controlling agents.